ArticleOncology letters2023

Safety and preliminary activity of pembrolizumab-carboplatin-paclitaxel in heavily pretreated and/or fragile patients with PDL1-positive recurrent/metastatic head and neck cancer.

Santiago Cabezas-Camarero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.